Vineeta TripathiFounder

United Kingdom - London, England

15+ years’ in Pharmaceutical drug development for biologics within Neuroscience, Immuno-Oncology and Ophthalmology, project management, target product profile, go-to market strategy. Co-founded Vitarka Therapeutics, currently fundraising Seed investment round. Academic expertise in discovery and validation of TDP-43 mutations causing Motor Neuron Disease. Proven track record of publications in journals such as Science and Nature; total citation score of >7000. Co-inventor on patents for chimeric neurotoxin NMEs and therapeutic antibodies. Delivered 2 candidates to clinic for wet AMD. Won 3rd place for the 1st Roche pRED Oncology Award for innovative scientific achievements in “Novel highly tumor-selective membrane targets for antibody-based cancer therapy”.